Thursday, January 23, 2025
HomeTagsCardiometabolic disease

cardiometabolic disease

General Proximity Raises $16M to Tackle ‘Undruggable’ Targets with Next-Gen Medicines

General Proximity, a breakthrough biotech platform company, announced its emergence from stealth, unveiling its proprietary OmniTAC platform designed to pioneer the next generation of...

Lilly to Acquire Versanis to Improve Patient Outcomes in Cardiometabolic Diseases

Eli Lilly and Company and Versanis Bio announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics